Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease

Free Radical Biology and Medicine

Volumn 25, Issue 8, 1998, Pages 898-902

  Smith, Mark A ^a   Vašák, Milan ^b   Knipp, Markus ^b   Castellani, Rudy J ^c   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Nitric oxide; Oxidative stress; Transition metals; Zinc

Indexed keywords

ARGINASE; METAL; NITRIC OXIDE SYNTHASE; REGULATOR PROTEIN; ZINC;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOSKELETON; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMIDOHYDROLASES; CYTOSKELETON; HIPPOCAMPUS; HUMANS; HYDROLASES; IMMUNOBLOTTING; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS;

EID: 0032533981     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00119-1     Document Type: Article

References (42)

1. Pappolla M.A., Omar R.A., Kim K.S., Robakis N.K. Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
2. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
3. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
4. Ledesma M.D., Bonay P., Colaco C., Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:1994;21614-21619.
5. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
6. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
7. Montine K.S., Olson S.J., Amarnath V., Whetsell W.O. Jr, Graham D.G., Montine T.J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150:1997;437-443.
8. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
9. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Marksberry W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
10. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
11. Smith M.A., Sayre L.M., Anderson V.E., Harris P.L.R., Beal M.F., Kowall N., Perry G. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with dinitrophenylhydrazine. J. Histochem. Cytochem. 46:1998;731-735.
12. Yan S.-D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.-S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.-H., Stern D. Glycated tau protein in Alzheimer disease a mechanism for induction of oxidant stress . Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
13. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA. 94:1997;9866-9868.
14. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain. Res. 760:1997;298-303.
15. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease a laser microprobe (LAMMA) study . Ann. Neurol. 31:1992;286-292.
16. Bush A.I., Moir R.D., Rosenkranz K.M., Tanzi R.E. Zinc and Alzheimer's disease. Science. 268:1995;1921-1923.
17. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease possible relation to oxidative stress . J. Neurol. Sci. 143:1996;137-142.
18. Cuajungco M.P., Lees G.J. Zinc and Alzheimer's disease is there a direct link? Brain Res. Rev. 23:1997;219-236.
19. G-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch. Biochem. Biophys. 300:1993;657-662.
20. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J. Biochem. 117:1995;237-238.
21. Bogumil R., Knipp M., Fundel S.M., Vašák M. Characterization of dimethylargininase from bovine brain evidence for a zinc binding site . Biochemistry. 37:1998;4791-4798.
22. McAllister R.J., Parry H., Kimoto M., Ogawa T., Russel R.J., Hodson H., Whitley G.S., Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Brit. J. Pharmacol. 119:1996;1533-1540.
23. Fundel S.M., Pountney D.L., Bogumil R., Gehrig P.M., Hasler D.W., Faller P., Vašák M. Isolation and characterization of a novel monomeric zinc- and heme-containing protein from bovine brain. FEBS Lett. 395:1996;33-38.
24. Sternberger L.A. Immunocytochemistry. 3rd Edition. 1986;Wiley, New York.
25. Manetto V., Perry G., Tabaton M., Mulvihill P., Fried V.A., Smith H.T., Gambetti P., Autilio-Gambetti L. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 85:1988;4501-4505.
26. Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994;42-47.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680-685.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications . Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
29. Schipper H.M., Cisse S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768.
30. Kotani K., Ueno S., Sano A., Kakimoto Y. Isolation and identification of methyl arginines from bovine brain. J. Neurochem. 58:1992;1127-1129.
31. G-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthase? Am. J. Physiol. 269:1995;C750-C756.
32. Wink D.A., Hanbauer I., Laval F., Cook J.A., Krishna M.C., Mitchell J.B. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann. NY Acad. Sci. 738:1994;265-278.
33. Hyman B.T., Marzloff K., Wenniger J.J., Dawson T.M., Bredt D.S., Snyder S.H. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:1992;818-820.
34. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.-W., Smith T.W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1433.
35. da Silva J.J.R.F., Williams R.J.P. The Biological Chemistry of the Elements. The Inorganic Chemistry of Life. 1991;Clarendon Press, Oxford.
36. Bush A.I., Multhaup G., Moir R.D., Williamson T.G., Small D.H., Rumble B., Pollwein P., Beyreuther K., Masters C.L. A novel zinc(II) binding site modulates the function of βA4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
37. Multhaup G., Bush A.I., Pollwein P., Masters C.L. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP). FEBS Lett. 355:1994;151-154.
38. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
39. Bush A.I., Pettingell W.H., Multhaup G., de Paradis M., Vonsattel J.P., Gusella J.F., Beyreuther K., Masters C.L., Tanzi R.E. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science. 265:1994;1464-1467.
40. Esler W.P., Stimson E.R., Jennings J.M., Ghilardi J.R., Mantyh P.W., Maggio J.E. Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro. J. Neurochem. 66:1996;723-732.
41. McLachlan D.R., Kruck T.P., Lukiw W.J., Krishnan S.S. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? Can. Med. Assoc. 145:1991;793-804.
42. Smith M.A., Wehr K., Harris P.L.R., Siedlak S.L., Connor J.R., Perry G. Abnormal localization of iron regulatory protein (IRP) in Alzheimer disease. Brain Res. 788:1998;232-236.